High-fat diet enhanced retinal dehydrogenase activity, but suppressed retinol dehydrogenase activity in liver of rats

Journal of Pharmacological Sciences

Volumn 127, Issue 4, 2015, Pages 430-438

  Zhang, Mian ^a   Liu, Can ^a   Hu, Meng Yue ^a   Zhang, Ji ^a   Xu, Ping ^a   Li, Feng ^a   Zhong, Ze Yu ^a   Liu, Li ^a   Liu, Xiao Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alcohol dehydrogenases; Hyperlipidemia; Retinaldehyde dehydrogenases; Retinoid; Retinol dehydrogenases

Indexed keywords

ALCOHOL DEHYDROGENASE; CHOLESTEROL; MESSENGER RNA; PRAVASTATIN; RETINAL DEHYDROGENASE; RETINOL; RETINOL DEHYDROGENASE; OXIDOREDUCTASE; RETINAL; RETINOIC ACID; RETINOID;

ADH1 GENE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DHRS9 GENE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SPECIFICITY; GENE; GENE EXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIPID DIET; LIVER; LIVER LEVEL; MALE; NONHUMAN; PROTEIN EXPRESSION; RALDH1 GENE; RAT; RDH10 GENE; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VITAMIN BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; ENZYMOLOGY; GENETICS; HYPERLIPIDEMIAS; METABOLISM; RETINA; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ALCOHOL OXIDOREDUCTASES; ANIMALS; CHOLESTEROL; DIET, HIGH-FAT; DOWN-REGULATION; GENE EXPRESSION; HEP G2 CELLS; HUMANS; HYPERLIPIDEMIAS; KIDNEY; LIVER; MALE; OXIDOREDUCTASES; RATS, SPRAGUE-DAWLEY; RETINA; RETINALDEHYDE; RETINOIDS; TRETINOIN; UP-REGULATION; VITAMIN A;

EID: 84935007292     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1016/j.jphs.2015.03.001     Document Type: Article

References (48)

1. Vendrell J, El Bekay R, Peral B, García-Fuentes E, Megia A, Macias-Gonzalez M, et al. Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology. 2011;152:4072-4079.
2. Nammi S, Koka S, Chinnala KM, Boini KM. Obesity: an overview on its current perspectives and treatment options. Nutr J. 2004;3:1-8.
3. Ziouzenkova O, Plutzky J. Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett. 2008;582:32-38.
4. Mark M, Ghyselinck NB, Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol. 2006;46:451-480.
5. Niederreither K, Dolle P. Retinoic acid in development: towards an integrated view. Nat Rev Genet. 2008;9:541-553.
6. Makishima M. Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci. 2005;97:177-183.
7. Chen G. Roles of vitamin A metabolism in the development of hepatic insulin resistance. ISRN Hepatol. 2013;2013.
8. Schwarz EJ, Reginato MJ, Shao D, Krakow SL, Lazar MA. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription. Mol Cell Biol. 1997;17:1552-1561.
9. Zhao S, Li R, Li Y, Chen W, Zhang Y, Chen G. Roles of vitamin A status and retinoids in glucose and fatty acid metabolism. Biochem Cell Biol. 2012;90:142-152.
10. Shirakami Y, Lee S-A, Clugston RD, Blaner WS. Hepatic metabolism of retinoids and disease associations. Biochim Biophys Acta. 2012;1821:124-136.
11. Napoli JL. Physiological insights into all-trans-retinoic acid biosynthesis. Biochim Biophys Acta. 2012;1821:152-167.
12. Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact. 2003;143:201-210.
13. Ross AC. Overview of retinoid metabolism. J Nutr. 1993;123:346-350.
14. Zhang M, Hu P, Krois CR, Kane MA, Napoli JL. Altered vitamin A homeostasis and increased size and adiposity in the rdh1-null mouse. FASEB J. 2007;21:2886-2896.
15. Molotkov A, Ghyselinck N, Chambon P, Duester G. Opposing actions of cellular retinol-binding protein and alcohol dehydrogenase control the balance between retinol storage and degradation. Biochem J. 2004;383:295-302.
16. Fan X, Molotkov A, Manabe S-I, Donmoyer CM, Deltour L, Foglio MH, et al. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol Cell Biol. 2003;23:4637-4648.
17. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, Viereck J, et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med. 2007;13:695-702.
18. Kiefer FW, Orasanu G, Nallamshetty S, Brown JD, Wang H, Luger P, et al. Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism. Endocrinology. 2012;153:3089-3099.
19. Villaça Chaves G, Gonçalves de Souza G, Cardoso de Matos A, Abrantes Peres DW, Pereira SE, Saboya CJ, et al. Serum retinol and P-carotene levels and risk factors for cardiovascular disease in morbid obesity. Int J Vitam Nutr Res. 2010;80:159-167.
20. Godala M, Materek-Kusmierkiewicz I, Moczulski D, Rutkowski M, Szatko F, Gaszynska E, et al. Estimation of plasma vitamin A, C and E levels in patients with metabolic syndrome. Pol Merkur Lekarski. 2014;36:320-323.
21. Ha AW, Jeong SY, Kang NE, Kim WK. Plasma adipocytokines and antioxidantsstatus in Korean overweight and obese females with dyslipidemia. Nutr Res Pract. 2014;8:417-424.
22. Tungtrongchitr R, Changbumrung S, Tungtrongchitr A, Schelp FP. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr. 2003;12:73-79.
23. Chaves GV, Pereira SE, Saboya CJ, Ramalho A. Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin A in individuals with class III obesity. Obes Surg. 2008;18:378-385.
24. Reed M, Meszaros K, Entes L, Claypool M, Pinkett J, Gadbois T, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 2000;49:1390-1394.
25. Chen G, Hu N, Liu L, Xie S, Wang P, Li J, et al. Pharmacokinetics of verapamil in diabetic rats induced by combination of high-fat diet and streptozotocin injection. Xenobiotica. 2011;41:494-500.
26. Liu C, Zhang M, Hu M-y, Guo H-f, Li J, Yu Y-l, et al. Increased glucagon-like peptide-1 secretion may be involved in antidiabetic effects of ginsenosides. J Endocrinol. 2013;217:185-196.
27. Li F, Zhang M, Xu D, Liu C, Zhong Z-y, Jia L-l, et al. Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure. Acta Pharmacol Sin. 2014;35:792-805.
28. Miwa H. High-performance liquid chromatographic determination of mono-, poly- and hydroxycarboxylic acids in foods and beverages as their 2-nitrophenylhydrazides. J Chromatogr A. 2000;881:365-385.
29. Willhite C, Chow F, Taylor M, Omaye S. Comparative pharmacokinetics of vitamin A (retinol) in rats and hamsters. Food Chem Toxicol. 1985;23:51-55.
30. Jia L-l, Zhong Z-y, Li F, Ling Z-l, Chen Y, Zhao W-m, et al. The aggravation of clozapine-induced hepatotoxicity by glycyrrhetinic acid in rats. J Pharmacol Sci. 2014;124:468-479.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
32. Leo MA, Kim C-I, Lieber CS. NAD+-dependent retinol dehydrogenase in liver microsomes. Arch Biochem Biophys. 1987;259:241-249.
33. Shih T, Hill D. Conversion of retinol to retinal by rat liver microsomes. Drug Metab Dispos. 1991;19:332-335.
34. Liu H, Xu X, Yang Z, Deng Y, Liu X, Xie L Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res. 2006;1123:245-252.
35. Duverger-van Bogaert M, Dierickx P, Stecca C, Crutzen M-C. Metabolic activation by a supernatant from human hepatoma cells: a possible alternative in mutagenic tests. Mutat Res. 1993;292:199-204.
36. Ehrlich V, Darroudi F, Uhl M, Steinkellner H, Gann M, Majer B, et al. Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem Toxicol. 2002;40:1085-1090.
37. Uehara Y, Miura S-i, von Eckardstein A, Abe S, Fujii A, Matsuo Y, et al. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis. 2007;191:11-21.
38. Yang YM, Huang DY, Liu GF, Zhong JC, Du K, Li YF, et al. Effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on vitamin A metabolism in mice. J Biochem Mol Toxicol. 2005;19:327-335.
39. Kane MA, Folias AE, Napoli JL. HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues. Anal Biochem. 2008;378:71-79.
40. Chen H, Howald WN, Juchau MR. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab Dispos. 2000;28:315-322.
41. Molotkov A, Deltour L, Foglio MH, Cuenca AE, Duester G. Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant mice. J Biol Chem. 2002;277:13804-13811.
42. El Akawi Z, Napoli JL. Rat liver cytosolic retinal dehydrogenase: comparison of 13-cis-, 9-cis-, and all-trans-retinal as substrates and effects of cellular retinoid-binding proteins and retinoic acid on activity. Biochemistry. 1994;33:1938-1943.
43. Muenzner M, Tuvia N, Deutschmann C, Witte N, Tolkachov A, Valai A, et al. Retinol-binding protein 4 and its membrane receptor STRA6 control adipogenesis by regulating cellular retinoid homeostasis and retinoic acid receptor a activity. Mol Cell Biol. 2013;33:4068-4082.
44. Li Y, Zhang Y, Li R, Chen W, Howell M, Zhang R, et al. The hepatic Raldh1 expression is elevated in zucker fatty rats and its over-expression introduced the retinal-induced Srebp-1c expression in INS-1 cells. PLoS One. 2012;7:e45210.
45. Ornoy A, Zaken V, Abir R, Yaffe P, Raz I. Effects on rat embryos of culture in serum of women with gestational diabetes. Toxicol In Vitro. 1995;9:643-651.
46. Münzel D, Lehle K, Haubner F, Schmid C, Birnbaum DE, Preuner JG. Impact of diabetic serum on endothelial cells: an in-vitro-analysis of endothelial dysfunction in diabetes mellitus type 2. Biochem Biophys Res Commun. 2007;362:238-244.
47. Liu X, Jing X, Jin S, Li Y, Liu L, Yu Y, et al. Insulin suppresses the expression and function of breast cancer resistance protein in primary cultures of rat brain microvessel endothelial cells. Pharmacol Rep. 2011;63:487-493.
48. Hu N, Hu M, Duan R, Liu C, Guo H, Zhang M, et al. Increased levels of fatty acids contributed to induction of hepatic CYP3A4 activity induced by diabetes-in vitro evidence from HepG2 cell and Fa2N-4 cell lines. J Pharmacol Sci. 2014;124:433-444.